BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16474575)

  • 21. Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells.
    Gunasekera RS; Sewgobind K; Desai S; Dunn L; Black HS; McKeehan WL; Patil B
    Nutr Cancer; 2007; 58(2):171-7. PubMed ID: 17640163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diet and prostate cancer: from prevention to treatment].
    Amsellem-Ouazana D; Conquy S
    Prog Urol; 2004 Sep; 14(4):573-6. PubMed ID: 15776917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future status of prostate cancer chemoprevention.
    Fujimoto N; Nomura M; Matsumoto T
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant and anti-proliferative properties of lycopene.
    Kelkel M; Schumacher M; Dicato M; Diederich M
    Free Radic Res; 2011 Aug; 45(8):925-40. PubMed ID: 21615277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses.
    Magri V; Trinchieri A; Perletti G; Marras E
    Arch Ital Urol Androl; 2008 Jun; 80(2):65-78. PubMed ID: 18683812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer prevention: past, present, and future.
    Fleshner N; Zlotta AR
    Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lycopene supplementation in patients with localized prostate cancer.
    Kucuk O; Sarkar FH; Djuric Z; Sakr W; Pollak MN; Khachik F; Banerjee M; Bertram JS; Wood DP
    Exp Biol Med (Maywood); 2002 Nov; 227(10):881-5. PubMed ID: 12424329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
    Van Patten CL; de Boer JG; Tomlinson Guns ES
    J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer properties of carotenoids in prostate cancer. A review.
    Soares Nda C; Teodoro AJ; Lotsch PF; Granjeiro JM; Borojevic R
    Histol Histopathol; 2015 Oct; 30(10):1143-54. PubMed ID: 26058846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial.
    van Breemen RB; Sharifi R; Viana M; Pajkovic N; Zhu D; Yuan L; Yang Y; Bowen PE; Stacewicz-Sapuntzakis M
    Cancer Prev Res (Phila); 2011 May; 4(5):711-8. PubMed ID: 21430075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial.
    Giovannucci E
    Cancer Causes Control; 2011 Jul; 22(7):1055-9. PubMed ID: 21573862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary and alternative medicine patients are talking about: lycopene.
    Lee CO
    Clin J Oncol Nurs; 2005 Apr; 9(2):245-6. PubMed ID: 15853167
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrative review of lycopene and breast cancer.
    Wane D; Lengacher CA
    Oncol Nurs Forum; 2006 Jan; 33(1):127-37. PubMed ID: 16470241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of recent evidence in support of a role for statins in the prevention of prostate cancer.
    Hamilton RJ; Freedland SJ
    Curr Opin Urol; 2008 May; 18(3):333-9. PubMed ID: 18382245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.
    Schwenke C; Ubrig B; Thürmann P; Eggersmann C; Roth S
    J Urol; 2009 Mar; 181(3):1098-103. PubMed ID: 19150092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer.
    Kristal AR
    J Urol; 2004 Feb; 171(2 Pt 2):S54-8; discussion S58. PubMed ID: 14713755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.
    Barber NJ; Zhang X; Zhu G; Pramanik R; Barber JA; Martin FL; Morris JD; Muir GH
    Prostate Cancer Prostatic Dis; 2006; 9(4):407-13. PubMed ID: 16983396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of alpha-vitamin E and its analogues in prostate cancer.
    Ni J; Yeh S
    Vitam Horm; 2007; 76():493-518. PubMed ID: 17628187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study.
    Karppi J; Kurl S; Nurmi T; Rissanen TH; Pukkala E; Nyyssönen K
    Ann Epidemiol; 2009 Jul; 19(7):512-8. PubMed ID: 19443241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tomato: an important part of the urologist's diet?
    Barber N
    BJU Int; 2003 Mar; 91(4):307-9. PubMed ID: 12603399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.